CurvaFix secures $39 million in funding and appoints new CEO.
CurvaFix, a company based in Bellevue, Washington, has recently announced the completion of a $39 million equity financing round and introduced Mark Foster as its new CEO. Foster will be taking over from founder and current CEO Steve Dimmer. CurvaFix specializes in the development of medical devices designed to repair fractures in curved bones. Following the leadership transition, Dimmer will assume a strategic advisory role within the company.
Leading the equity financing was MVM Partners, with participation from Sectoral Asset Management and other existing investors. The funds raised will be utilized by CurvaFix to expand the treatment of fragility fractures of the pelvis (FFP) across the United States. The company aims to launch its CurvaFix IM implant nationwide, as mentioned in their news release.
Eric Fritz, a partner at MVM, expressed enthusiasm about CurvaFix’s potential, stating that the company’s ability to address the undertreated FFP segment while benefiting patients, physicians, and health systems makes it a valuable asset in the competitive field of orthopedics. MVM is delighted to be involved and is committed to supporting CurvaFix’s growth in the upcoming phase.
Mark Foster brings his experience as the former president and CEO of Trice Medical, a developer of minimally invasive orthopedic technology, to his new role at CurvaFix. He has also held the position of VP of U.S. sports medicine at Smith+Nephew and has had leadership positions at Boston Scientific. Foster acknowledged Steve Dimmer’s significant contribution in bringing CurvaFix to its current position, specifically in the successful implementation and adoption of CurvaFix IM Implants within the orthopedic pelvic fracture fixation market. Foster looks forward to leading the CurvaFix team and scaling the company’s technology to benefit a larger number of patients, physicians, and payers.
© CurvaFix Inc